HonorHealth Research Institute is among first in the nation to expand access to new drug that doubles survival of pancreatic cancer patients
Business Announcement
Updates every hour. Last Updated: 26-Oct-2026 07:16 ET (26-Oct-2026 11:16 GMT/UTC)
Under an FDA ruling that expands access to clinical trials, HonorHealth Research Institute is one of the first in the nation to offer a new drug, Daraxonrasib, that based on early data nearly doubles the average survival time of patients with pancreatic cancer.
The American College of Medical Genetics and Genomics (ACMG) announced today that its flagship journal, Genetics in Medicine (GIM), maintained a 2025 Journal Impact Factor of 6.2 and continues to rank in the first quartile (Q1) of journals in the Genetics category, according to the latest Journal Citation Reports™ from Clarivate.
CAMBRIDGE, Mass., July 7, 2026 — Insilico Medicine (“Insilico,” HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its potentially first-in-class oral small-molecule inhibitor targeting TNIK for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive, age-related fibrotic lung disease with high unmet medical need.
While caregiving can be meaningful and rewarding at manageable levels, those who spend more than 20 hours a week delivering unpaid care to others have poorer mental health outcomes, a McGill study has found.
Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a five-year, $7.2 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to establish a new Asthma and Allergic Diseases Cooperative Research Center focused on advancing personalized treatment strategies for peanut allergy.